CGON

CG Oncology, Inc. Common stock (CGON)

US
$ 26.30.42%

Price Chart

Key Statistics

Market Cap
$ 1.89B
P/E Ratio
0.00
Revenue (TTM)
$ 662K
Volume
651.13K
52W High
$ 40.47
52W Low
$ 14.80
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
23.863
200-Day MA
30.71
52 Week High
40.47
52 Week Low
14.8

About CGON

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Employees
113
Headquarters
Irvine, CA
CEO
Mr. Arthur Kuan

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
BLMZ
BloomZ Inc. Ordinar...
$ 0.24
136.74
EDBL
Edible Garden AG In...
$ 3.85
92.50
TNMG
TNL Mediagene Ordin...
$ 1.03
72.85
SYTA
Siyata Mobile Inc. ...
$ 6.79
66.83
NRXS
Neuraxis Inc. Commo...
$ 3.71
63.44

Top Losers

Symbol/Name
LTP
% Chg
PTIX
Protagenic Therapeu...
$ 6.03
-45.68
NWTN
NWTN Inc. Class B O...
$ 2.40
-21.57
KIDZ
Classover Holdings ...
$ 2.70
-11.48
BCLI
Brainstorm Cell The...
$ 1.21
-11.03
TOVX
Theriva Biologics I...
$ 0.45
-10.02